&w=3840&q=100)
Paytm, Eternal surge up to 6%, stocks near 52-week highs
The stock price of the fintech company has surpassed its previous high of ₹1,128, touched on July 24, 2025. In the past month, the stock surged 24 per cent.
Meanwhile, shares of Eternal, the parent company of food aggregator Zomato and quick-commerce firm Blinkit, were up 3 per cent to ₹310.40 in intra-day trade. The stock is quoting close to its record high level of ₹314.40, touched on July 24, 2025.
Antfin offloads stake in Eternal, Paytm via open market
On August 7, 2025, Antfin Singapore Holding offloaded a 1.46 per cent stake in Eternal (formerly Zomato) via block deals. The Chinese investor sold 141.3 million shares at a price of ₹289.91 per share, NSE bulk deal data shows.
On August 5, 2025, Antfin (Netherlands) Holding B.V. sold its entire 5.84 per cent stake for around ₹4,000 crore. According to BSE bulk deals data, Antfin (Netherlands) Holding B.V. sold 18.64 million shares in two tranches. Antfin (Netherlands) Holding BV is the entity of the Chinese technology conglomerate Alibaba Group.
Brokerages' view on Paytm, Eternal
Yes Securities maintained an 'Add' rating on Paytm with a revised price target of ₹1,200. Management stated that the Payments business is already profitable on a standalone basis without merchant discount rate (MDR) on UPI and will be a large profitability driver when MDR-bearing form factors grow. Net payments margin is going to rise because of a rise in credit cards, EMI and loyalty points.
Emkay Global Financial Services believes lenders' willingness to offer loans without a Default Loss Guarantee (DLG) is a testimony to the improved asset quality of the merchant loan portfolio. Paytm is executing well on acquiring merchants, leveraging its superior Soundbox products and distributing loans to them.
With low penetration of loans, the brokerage firm sees a long growth runway for this business. Considering cash on books of ₹1,290 crore, the long growth runway for payments and financial services, and the various opportunities, the brokerage firm believes the risk-return is attractive. It retains a 'Buy' rating on the stock with a target price of ₹1,350.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
3 minutes ago
- Mint
INOX Green share price jumps after inking 182 MW wind project. Check details
Inox Green Energy share price rose by almost 5% during Tuesday's trading session following the company's signing of a deal with one of India's major conglomerates for the complete operations and maintenance (O&M) of 182 MW of existing wind projects within its renewable energy division. The projects, situated across various locations in Western India, are linked to Inox Green's shared infrastructure. The agreement includes upgrading from limited-scope to full O&M for 82 MW of wind projects, as well as the early renewal of full O&M for an additional 100 MW. The contract will cover the entire remaining lifespan of the project. "We are thrilled to reveal the signing of comprehensive O&M contracts for 182 MW with the renewable division of one of India's largest conglomerates. This represents a significant milestone for us, as the signing brings our complete fleet with this prestigious customer back under our management," stated SK Mathu Sudhana, CEO of Inox Green. "This demonstrates the evolving dynamics within the wind O&M sector and reinforces the confidence that our customers are placing in our enhanced capabilities,' he continued. A board meeting for Inox Green is set for August 14, 2025, to review, approve, and document the unaudited standalone and consolidated financial results for the quarter ending June 30, 2025. Inox Green Energy share price today opened at ₹ 158 apiece on the BSE, the stock touched an intraday high of ₹ 163.40 per share, and an intraday low of ₹ 157.95 per share. According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One,Inox Green Energy share prices are showing strong traction in today's session, after holding on to key support levels of 200DSMA since last three sessions, the positive momentum could continue towards 170 with 153 remains a key support. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.
Mint
3 minutes ago
- Mint
Motilal Oswal sees this multibagger AMC stock rising 15% to fresh record high. Should you buy?
Domestic brokerage firm Motilal Oswal, in its latest note, has maintained an optimistic outlook on Nippon Life India AMC, keeping its buy rating unchanged with a target price of ₹ 930 apiece, a record target for the stock. The target price also indicates an 15.4% upside for the stock. The brokerage highlighted the company's rapid growth in the domestic mutual fund industry, with expanding market share supported by consistent net inflows, strong SIP traction, and a healthy equity mix. According to Motilal, the company has delivered the fastest Quarterly Average Assets Under Management (QAAUM) growth in the industry, rising 27% YoY to ₹ 6.1 trillion as of June 2025. This growth has lifted the company's overall market share to 8.5%, an increase of 23 basis points. Its SIP AUM rose 27% YoY to ₹ 1.5 trillion, with 75% of SIPs below ₹ 10,000, a structure that ensures stability and high retention. The brokerage noted that NAM remains one of the largest ETF players, with an AUM of ₹ 1.7 trillion, accounting for 52% of industry folios and 51% of ETF volumes on the BSE and NSE. As of June 2025, NAM's Gold ETF ranked among the world's top 10 by AUM. Motilal also underscored the company's progress in scaling its alternatives and offshore businesses, with ₹ 81 billion in AIF commitments and ₹ 166 billion in offshore AUM. The brokerage believes these segments will serve as incremental growth levers beyond the core mutual fund franchise, gaining increasing traction from institutional and global investors. 'NAM is strategically scaling its Specialized Investment Fund (SIF) platform as a high-potential standalone business focused on differentiated, alpha-generating strategies. Backed by a dedicated team and strong management commitment, the SIF vertical is being positioned as a key long-term growth engine,' said the brokerage. It also pointed out that the company's mutual fund segment performance reflects its focused strategy on scaling retail participation, driving product innovation, and enhancing operational efficiency, positioning it as a credible compounding franchise in the Indian asset management industry. The company's shares have been on a steady uptrend, ending the past four months in the green. Even in July, they managed to close higher despite a sharp sell-off in the broader market, while also hitting a fresh all-time high of ₹ 877.65. This rally has driven a 255% gain from the March 2023 lows. During this period, the stock finished 80% of the months in positive territory, with its strongest month recorded in April 2025, a 25% gain. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Hans India
3 minutes ago
- Hans India
Rainbow Children's Medicare to acquire 76 pc stake in Pratiksha Hospital
Multi-speciality pediatric hospital chain Rainbow Children's Medicare Ltd on Tuesday said it will acquire a 76 per cent stake in Guwahati-based Pratiksha Hospital for around Rs 171 crore. The Hyderabad-based healthcare firm has inked a definitive agreement with promoters of Pratiksha Hospital for the stake buy. The transaction values Pratiksha Hospital at an enterprise valuation of Rs 171 crore, fully funded via the company's cash reserves and internal accruals, Rainbow Children's Medicare Ltd (RCML) said in a statement. RCML will acquire a 76 per cent controlling stake, while promoter Dr Sharma & his family will retain the balance share in Pratiksha Hospital, it added. Founded in 1995 by Pramod Kumar Sharma, a pioneer of IVF, minimal invasive gynaecology surgery in Northeast India, Pratiksha Hospital commenced operations in Guwahati and subsequently delivered its first IVF baby in February 1997. "This partnership empowers us to reach a wider community and deliver top-tier pediatric and maternal care to the families of Assam and Northeast India," RCML Chairman & MD Ramesh Kancharla said. Shares of the company were trading 2.41 per cent up at Rs 1,540 apiece on BSE.
